Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma
Open Access
- 19 November 2018
- journal article
- research article
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 13 (1) , 119
Abstract
The introduction of the new TNM staging system for thymic epithelial malignancies produced a significant increase in the proportion of patients with stage I disease. The identification of new prognostic factors could help to select patients for adjuvant therapies based on their risk of recurrence. Neutrophil-to-lymphocyte ratio (NLR) has recently gained popularity as reliable prognostic biomarker in many different solid tumors. The aim of this study is to assess the utility of NLR evaluation as a prognostic marker in patients with surgically-treated thymoma. A retrospective analysis was conducted among patients who underwent resection for thymoma in a single center. Patients were divided in two groups, under (low-NLR-Group = 47 patients, 60%) and above (high-NLR-Group = 32 patients, 40%) a ROC-derived NLR cut-off (2.27). Associations with clinical-pathological variables were analyzed; disease-free survival (DFS) was identified as the primary endpoint. Between 2007 and 2017, 79 patients had surgery for thymoma. Overall 5-year DFS was 80%. Univariate survival analysis demonstrated that NLR was significantly related to DFS when patients were stratified for TNM stage (p = 0.043). Five-year DFS in the low-NLR-Group and in the high-NLR-Group were respectively 100 and 84% in stage I-II, and 66 and 0% in stage III. TNM stage resulted as the only independent prognostic factor at multivariate analysis, with hazard ratio of 3.986 (95% CI 1.644–9.665, p = 0.002). High preoperative NLR seems to be associated to a shorter DFS in patients submitted to surgery for thymoma and stratified for TNM stage.Keywords
This publication has 29 references indexed in Scilit:
- Clinical evaluation of a new tumour–node–metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest GroupEuropean Journal of Cardio-Thoracic Surgery, 2015
- A Review of the Place and Role of Radiotherapy in ThymomaClinical Lung Cancer, 2015
- Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2015
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-AnalysisJNCI: Journal of the National Cancer Institute, 2014
- Late distant metastases of malignant thymoma associated with peripheral T‐cell lymphocytosisPathology International, 2013
- Thymoma and thymic carcinomaGeneral Thoracic and Cardiovascular Surgery, 2012
- Standard Terms, Definitions, and Policies for Minimally Invasive Resection of ThymomaJournal of Thoracic Oncology, 2011
- Prognostic Predictors and Long-Term Outcome of Postoperative Irradiation in Thymoma: A Study of 241 PatientsCancer Investigation, 2009
- Mature, long‐lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravisAnnals of Neurology, 2001
- A review of 79 thymomas: Modification of staging system and reappraisal of conventional division into invasive and non‐invasive thymomaPathology International, 1994